Tranquillus in Exile
New member
The world's first coronavirus treatment that significantly reduces the risk of death is being given to NHS patients following groundbreaking trials by British scientists. The common steroid dexamethasone was shown to radically improve the chances of survival for the most ill patients.
The drug – commonly used to treat arthritis, severe allergies and asthma – costs just £5 for a full course of treatment and is expected to have a major impact on the coronavirus pandemic.
Martin Landray, the deputy chief investigator from the University of Oxford, said: "Since the advent of this disease less than six months ago, the search has been on for a treatment that actually reduces the risk of dying, and there hasn't been one until today. Now there is one. This is not an expensive drug, this is not a drug where there are supply chain issues or manufacturing issues. This is a drug that is globally available – so that is enormously important."
The results are part of a trial set up in March to test a range of potential treatments for Covid-19. More than 11,500 patients have been enrolled from over 175 NHS hospitals in the UK, including 2,100 on the dexamethasone trial.
Peter Horby, Professor of Emerging Infectious Diseases and Global Health in the Nuffield Department of Medicine and the chief investigator of the trial, said: "This is the only drug that has so far been shown to reduce mortality and it reduces it significantly. The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become standard of care in these patients.”
https://www.telegraph.co.uk/news/20...deaths-one-third-severe-coronavirus-patients/
The drug – commonly used to treat arthritis, severe allergies and asthma – costs just £5 for a full course of treatment and is expected to have a major impact on the coronavirus pandemic.
Martin Landray, the deputy chief investigator from the University of Oxford, said: "Since the advent of this disease less than six months ago, the search has been on for a treatment that actually reduces the risk of dying, and there hasn't been one until today. Now there is one. This is not an expensive drug, this is not a drug where there are supply chain issues or manufacturing issues. This is a drug that is globally available – so that is enormously important."
The results are part of a trial set up in March to test a range of potential treatments for Covid-19. More than 11,500 patients have been enrolled from over 175 NHS hospitals in the UK, including 2,100 on the dexamethasone trial.
Peter Horby, Professor of Emerging Infectious Diseases and Global Health in the Nuffield Department of Medicine and the chief investigator of the trial, said: "This is the only drug that has so far been shown to reduce mortality and it reduces it significantly. The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become standard of care in these patients.”
https://www.telegraph.co.uk/news/20...deaths-one-third-severe-coronavirus-patients/